Drug discovery in cancer epigenetics:
Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy predictio...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Oxford Waltham, MA
Academic Press, an imprint of Elsevier
[2016]
|
| Schriftenreihe: | Translational epigenetics series
|
| Schlagworte: | |
| Online-Zugang: | FAW01 URL des Erstveröffentlichers |
| Zusammenfassung: | Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic |
| Beschreibung: | Includes bibliographical references (pages 449-456) and index |
| Beschreibung: | 1 online resource (xxi, 475 pages) |
| ISBN: | 9780128024928 0128024925 9780128022085 0128022086 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044392188 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170630s2016 |||| o||u| ||||||eng d | ||
| 020 | |a 9780128024928 |9 978-0-12-802492-8 | ||
| 020 | |a 0128024925 |9 0-12-802492-5 | ||
| 020 | |a 9780128022085 |9 978-0-12-802208-5 | ||
| 020 | |a 0128022086 |9 0-12-802208-6 | ||
| 035 | |a (ZDB-33-ESD)ocn930600931 | ||
| 035 | |a (OCoLC)930600931 | ||
| 035 | |a (DE-599)BVBBV044392188 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 616.99/4042 |2 23 | |
| 245 | 1 | 0 | |a Drug discovery in cancer epigenetics |c edited by Gerda Egger and Paola Arimondo |
| 264 | 1 | |a Oxford |a Waltham, MA |b Academic Press, an imprint of Elsevier |c [2016] | |
| 264 | 4 | |c © 2016 | |
| 300 | |a 1 online resource (xxi, 475 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Translational epigenetics series | |
| 500 | |a Includes bibliographical references (pages 449-456) and index | ||
| 520 | |a Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic | ||
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
| 650 | 7 | |a Cancer / Genetic aspects |2 fast | |
| 650 | 7 | |a Epigenetics |2 fast | |
| 650 | 7 | |a Gene expression |2 fast | |
| 650 | 4 | |a Evidenz-basierte Medizin | |
| 650 | 4 | |a Innere Medizin | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Cancer |x Genetic aspects | |
| 650 | 4 | |a Epigenetics | |
| 650 | 4 | |a Gene expression | |
| 700 | 1 | |a Egger, Gerda |4 edt | |
| 700 | 1 | |a Arimondo, Paola |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780128022085 |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780128022085 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029794410 | ||
| 966 | e | |u http://www.sciencedirect.com/science/book/9780128022085 |l FAW01 |p ZDB-33-ESD |q FAW_PDA_ESD |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804177666214985728 |
|---|---|
| any_adam_object | |
| author2 | Egger, Gerda Arimondo, Paola |
| author2_role | edt edt |
| author2_variant | g e ge p a pa |
| author_facet | Egger, Gerda Arimondo, Paola |
| building | Verbundindex |
| bvnumber | BV044392188 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (ZDB-33-ESD)ocn930600931 (OCoLC)930600931 (DE-599)BVBBV044392188 |
| dewey-full | 616.99/4042 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4042 |
| dewey-search | 616.99/4042 |
| dewey-sort | 3616.99 44042 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03069nmm a2200589zc 4500</leader><controlfield tag="001">BV044392188</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170630s2016 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128024928</subfield><subfield code="9">978-0-12-802492-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0128024925</subfield><subfield code="9">0-12-802492-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128022085</subfield><subfield code="9">978-0-12-802208-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0128022086</subfield><subfield code="9">0-12-802208-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-ESD)ocn930600931</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)930600931</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044392188</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4042</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug discovery in cancer epigenetics</subfield><subfield code="c">edited by Gerda Egger and Paola Arimondo</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="a">Waltham, MA</subfield><subfield code="b">Academic Press, an imprint of Elsevier</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xxi, 475 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Translational epigenetics series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 449-456) and index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Genetic aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epigenetics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gene expression</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Genetic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epigenetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene expression</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Egger, Gerda</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arimondo, Paola</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780128022085</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780128022085</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029794410</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9780128022085</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FAW_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044392188 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:51:42Z |
| institution | BVB |
| isbn | 9780128024928 0128024925 9780128022085 0128022086 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029794410 |
| oclc_num | 930600931 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 online resource (xxi, 475 pages) |
| psigel | ZDB-33-ESD ZDB-33-EBS ZDB-33-ESD FAW_PDA_ESD |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Academic Press, an imprint of Elsevier |
| record_format | marc |
| series2 | Translational epigenetics series |
| spelling | Drug discovery in cancer epigenetics edited by Gerda Egger and Paola Arimondo Oxford Waltham, MA Academic Press, an imprint of Elsevier [2016] © 2016 1 online resource (xxi, 475 pages) txt rdacontent c rdamedia cr rdacarrier Translational epigenetics series Includes bibliographical references (pages 449-456) and index Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cancer / Genetic aspects fast Epigenetics fast Gene expression fast Evidenz-basierte Medizin Innere Medizin Medizin Cancer Genetic aspects Epigenetics Gene expression Egger, Gerda edt Arimondo, Paola edt Erscheint auch als Druck-Ausgabe 9780128022085 http://www.sciencedirect.com/science/book/9780128022085 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Drug discovery in cancer epigenetics HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cancer / Genetic aspects fast Epigenetics fast Gene expression fast Evidenz-basierte Medizin Innere Medizin Medizin Cancer Genetic aspects Epigenetics Gene expression |
| title | Drug discovery in cancer epigenetics |
| title_auth | Drug discovery in cancer epigenetics |
| title_exact_search | Drug discovery in cancer epigenetics |
| title_full | Drug discovery in cancer epigenetics edited by Gerda Egger and Paola Arimondo |
| title_fullStr | Drug discovery in cancer epigenetics edited by Gerda Egger and Paola Arimondo |
| title_full_unstemmed | Drug discovery in cancer epigenetics edited by Gerda Egger and Paola Arimondo |
| title_short | Drug discovery in cancer epigenetics |
| title_sort | drug discovery in cancer epigenetics |
| topic | HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cancer / Genetic aspects fast Epigenetics fast Gene expression fast Evidenz-basierte Medizin Innere Medizin Medizin Cancer Genetic aspects Epigenetics Gene expression |
| topic_facet | HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Cancer / Genetic aspects Epigenetics Gene expression Evidenz-basierte Medizin Innere Medizin Medizin Cancer Genetic aspects |
| url | http://www.sciencedirect.com/science/book/9780128022085 |
| work_keys_str_mv | AT eggergerda drugdiscoveryincancerepigenetics AT arimondopaola drugdiscoveryincancerepigenetics |